Search

everythinglearnresearchcommunity

for

Search:↓

Terbinafine can cause hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

A Thai boy was diagnosed with a rare hair disorder causing hair thinning and shedding.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

Oral cyclosporin doesn't stop hair loss.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Premature graying of hair is common and stressful, but not well understood or treated.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Iron supplements may reverse premature hair graying caused by iron deficiency.

Mutations in the P2RY5 gene cause hereditary woolly hair.

Cyclosporin doesn't stop hair loss.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Sunlight simulation causes skin inflammation, with different skin types reacting at different levels of exposure.

Minoxidil in Espumil foam stays stable for at least 90 days at room temperature.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.